# Bambusa Therapeutics, Inc. — Form D

Bambusa Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-26. The offering totals $88.9M, of which $53.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-02-26
- Form: D
- Accession: 0002044950-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $88.9M
- Amount sold: $53.3M
- Remaining: $35.6M
- Investors: 16
- Date of first sale: 2025-02-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-539297

## Issuer

- Name: Bambusa Therapeutics, Inc.
- CIK: 0002044950
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: ONE MARINA PARK DRIVE, SUITE 1410, BOSTON, MA, 02210
- Phone: 949-887-7927

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Derek DiRocco | Director | Boston, MA |
| Helmut Jeggle | Director | Boston, MA |
| Sean Marett | Director | Boston, MA |
| Shanshan Xu | Director | Boston, MA |
| Shanshan Xu | Executive Officer | Boston, MA |
| Shanshan Xu | Promoter | Boston, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-01-08](https://search.stillhousedata.com/formd/0002044950-25-000002) | D | $9.0M | $9.0M |
| [2025-01-08](https://search.stillhousedata.com/formd/0002044950-25-000001) | D | $5.1M | $5.1M |

## More

- [CIK 2044950 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2044950&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002044950-25-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.